BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17084795)

  • 1. Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problems.
    Palepu A; Cheng DM; Kim T; Nunes D; Vidaver J; Alperen J; Saitz R; Samet JH
    J Subst Abuse Treat; 2006 Dec; 31(4):411-7. PubMed ID: 17084795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse treatment and hospitalization among a cohort of HIV-infected individuals with alcohol problems.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Alcohol Clin Exp Res; 2005 Mar; 29(3):389-94. PubMed ID: 15770114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse treatment and emergency department utilization among a cohort of HIV-infected persons with alcohol problems.
    Palepu A; Horton NJ; Tibbetts N; Dukes K; Meli S; Samet JH
    J Subst Abuse Treat; 2003 Jul; 25(1):37-42. PubMed ID: 14512106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of specialty substance use treatment among adults with opioid use disorders.
    Romo E; Ulbricht CM; Clark RE; Lapane KL
    Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mental health and substance abuse treatment services among adults with HIV in the United States.
    Burnam MA; Bing EG; Morton SC; Sherbourne C; Fleishman JA; London AS; Vitiello B; Stein M; Bozzette SA; Shapiro MF
    Arch Gen Psychiatry; 2001 Aug; 58(8):729-36. PubMed ID: 11483138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems.
    Orwat J; Saitz R; Tompkins CP; Cheng DM; Dentato MP; Samet JH
    J Subst Abuse Treat; 2011 Oct; 41(3):233-42. PubMed ID: 21700412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients.
    Mertens JR; Flisher AJ; Satre DD; Weisner CM
    Drug Alcohol Depend; 2008 Nov; 98(1-2):45-53. PubMed ID: 18571875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems.
    Palepu A; Raj A; Horton NJ; Tibbetts N; Meli S; Samet JH
    J Subst Abuse Treat; 2005 Jan; 28(1):3-9. PubMed ID: 15723726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.
    Curcio F; Villano G; Masucci S; Plenzik M; Veneruso C; De Rosa G
    J Addict Med; 2011 Mar; 5(1):43-9. PubMed ID: 21769046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of treatment receipt among adults with a drug use disorder.
    Epstein JF; Hourani LL; Heller DC
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):841-69. PubMed ID: 15624552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C management by addiction medicine physicians: results from a national survey.
    Litwin AH; Kunins HV; Berg KM; Federman AD; Heavner KK; Gourevitch MN; Arnsten JH
    J Subst Abuse Treat; 2007 Jul; 33(1):99-105. PubMed ID: 17379472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders.
    Wenzel SL; Audrey Burnam M; Koegel P; Morton SC; Miu A; Jinnett KJ; Greer Sullivan J
    Med Care; 2001 Nov; 39(11):1158-69. PubMed ID: 11606870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study.
    Foster MA; Xing J; Moorman AC; Boscarino J; Gordon SC; Lu M; Rupp L; Schmidt MA; Trinacty CM; Xu F; Holmberg SD; Spradling PR
    Dig Dis Sci; 2016 Dec; 61(12):3469-3477. PubMed ID: 27510752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
    Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
    HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.
    Yeung MW; Young J; Moodie E; Rollet-Kurhajec KC; Schwartzman K; Greenaway C; Cooper C; Cox J; Gill J; Hull M; Walmsley S; Klein MB
    HIV Clin Trials; 2015; 16(3):100-10. PubMed ID: 25972048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.